PCN20 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN THE UNITED KINGDOM
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65178-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)65178-9/fulltext
Title :
PCN20 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUX®) IN COMBINATION WITH RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65178-9&doi=10.1016/S1098-3015(10)65178-9
First page :
Section Title :
Open access? :
No
Section Order :
338